Keyphrases
Adipocyte
100%
Cellular Mechanisms
100%
Protease Inhibitors
100%
HIV Infection
100%
HIV Treatment
100%
HIV-associated Lipodystrophy Syndrome
100%
Intermediary Metabolism
100%
Fat Storage
100%
Adverse Effects
50%
Dyslipidemia
50%
Insulin Resistance
50%
Metabolic Syndrome
50%
Molecular Mechanism
50%
Pathologic
50%
Physiologic
50%
Metabolic Effects
50%
Stress Response
50%
Chronic Inflammation
50%
Insulin
50%
Adipose Tissue
50%
Waist-to-hip Ratio
50%
Body Fat Distribution
50%
Drug Class
50%
Insulin Action
50%
Clinical Phenotype
50%
Circulating Lipids
50%
Lipotoxicity
50%
Dietary Lipids
50%
Metabolic Complications
50%
Lean muscle
50%
Stimulatory Effect
50%
HIV Protease Inhibitors
50%
Muscle Tissue
50%
Liver Tissue
50%
Lipid Metabolites
50%
Storage Capacity
50%
Peripheral Adipose Tissues
50%
Lipoatrophy
50%
Homeostatic Stress
50%
Medicine and Dentistry
Adipose Tissue
100%
Cellular Mechanism
100%
Lipid Storage
100%
Proteinase Inhibitor
100%
Human Immunodeficiency Virus Infection
100%
Metabolism
100%
HIV-associated Lipodystrophy
100%
Adipocyte
100%
In Vitro
50%
Insulin Resistance
50%
Chronic Inflammation
50%
Dyslipidemia
50%
Metabolic Syndrome
50%
Lipotoxicity
50%
Fat Intake
50%
Human Immunodeficiency Virus Proteinase Inhibitor
50%
Liver Tissue
50%
Body Fat Distribution
50%
Lipoatrophy
50%
Lipid Metabolite
50%
Adverse Effect
50%
Pharmacology, Toxicology and Pharmaceutical Science
Proteinase Inhibitor
100%
Human Immunodeficiency Virus Infection
100%
HIV Associated Lipodystrophy
100%
Insulin Resistance
50%
Dyslipidemia
50%
Metabolic Syndrome X
50%
Lipotoxicity
50%
Chronic Inflammation
50%
Human Immunodeficiency Virus Proteinase Inhibitor
50%
Lipoatrophy
50%
Biochemistry, Genetics and Molecular Biology
Human Immunodeficiency Virus
100%
Protease Inhibitor
100%
Adipocyte
66%
Metabolic Pathway
66%
Lipid Storage
66%
Dyslipidemia
33%
Insulin Resistance
33%
Lipid
33%
Metabolite
33%
Body Fat Distribution
33%
Lipotoxicity
33%
HIV Protease Inhibitor
33%